The AKT1 gene is associated with attention and brain morphology in schizophrenia

Abstract Objectives. A meta-analysis of the associations between genetic variants in the AKT1 gene and schizophrenia found that a single nucleotide polymorphism (SNP5; rs2494732) was associated with schizophrenia in Asian populations. Methods. In this study, we investigated the effects of this SNP on memory and attentional performance and brain structure using magnetic resonance imaging in a Japanese population (117 patients with schizophrenia and 189 healthy subjects). Results. The memory performance, particularly attention/concentration score, measured by the Wechsler Memory Scale-Revised in A carriers of SNP5, which was found to be enriched in patients with schizophrenia, was lower than that in individuals with the G/G genotype. We confirmed the association of the SNP with attentional performance using the Continuous Performance Test, which assessed sustained attention and vigilance of attentional function. Patients with A allele demonstrated lower attentional performance than patients with the G/G genotype. Patients with the A allele had smaller gray matter volumes in the right inferior parietal lobule related to attentional processes and in the frontostriatal region related to different SNPs in AKT1 than patients with the G/G genotype. Conclusions. Our results suggest that a genetic variant of AKT1 might be associated with attentional deficits and brain morphological vulnerability in patients with schizophrenia.

[1]  T. Arinami,et al.  Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case–control population , 2004, Molecular Psychiatry.

[2]  B. Kolachana,et al.  Epistatic and Functional Interactions of Catechol-O-Methyltransferase (COMT) and AKT1 on Neuregulin1-ErbB Signaling in Cell Models , 2010, PloS one.

[3]  T. Asada,et al.  Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia , 2006, Journal of neurochemistry.

[4]  U. Kang,et al.  The effects of clozapine on the GSK‐3‐mediated signaling pathway , 2004, FEBS letters.

[5]  M. Ikeda,et al.  Association of AKT1 with schizophrenia confirmed in a Japanese population , 2004, Biological Psychiatry.

[6]  D. Weinberger,et al.  Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia , 2007, Molecular Psychiatry.

[7]  Yusuke Nakamura,et al.  Case–control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population , 2009, Journal of Human Genetics.

[8]  J. Callicott,et al.  Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer? , 2008, Molecular Psychiatry.

[9]  M. Egan,et al.  Verbal and visual memory: Characterizing the clinical and intermediate phenotype in schizophrenia , 2008, Schizophrenia Research.

[10]  W. Maier,et al.  Further Evidence for Association of Variants in the AKT1 Gene with Schizophrenia in a Sample of European Sib-Pair Families , 2005, Biological Psychiatry.

[11]  M. Egan,et al.  Prefrontal neurons and the genetics of schizophrenia , 2001, Biological Psychiatry.

[12]  E. Bullmore,et al.  Anatomy of bipolar disorder and schizophrenia: A meta-analysis , 2010, Schizophrenia Research.

[13]  Takahisa Taguchi,et al.  Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. , 2006, Human molecular genetics.

[14]  R. Gainetdinov,et al.  The Akt-GSK-3 signaling cascade in the actions of dopamine. , 2007, Trends in pharmacological sciences.

[15]  P. Pavlidis,et al.  Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning , 2006, Proceedings of the National Academy of Sciences.

[16]  T. Robbins,et al.  Frontal-striatal cognitive deficits in patients with chronic schizophrenia. , 1997, Brain : a journal of neurology.

[17]  I. Gottesman,et al.  Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. , 2000, American journal of medical genetics.

[18]  Zhongming Zhao,et al.  Candidate genes for schizophrenia: A survey of association studies and gene ranking , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[19]  I. Lucki,et al.  Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function , 2012, Hippocampus.

[20]  Carles Falcón,et al.  Decreased cerebral activation during CPT performance structural and functional deficits in schizophrenic patients , 2004, NeuroImage.

[21]  Jianxin Shi,et al.  No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. , 2008, The American journal of psychiatry.

[22]  A. Levine,et al.  Detection of functional single-nucleotide polymorphisms that affect apoptosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Jope,et al.  The multifaceted roles of glycogen synthase kinase 3β in cellular signaling , 2001, Progress in Neurobiology.

[24]  M. Tsuang.  Schizophrenia: genes and environment , 2000, Biological Psychiatry.

[25]  A. Meyer-Lindenberg,et al.  Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. , 2008, The Journal of clinical investigation.

[26]  Jing Wang,et al.  Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex. , 2008, Learning & memory.

[27]  M. Leboyer,et al.  Association of AKT1 gene variants and protein expression in both schizophrenia and bipolar disorder , 2010, Genes, brain, and behavior.

[28]  G. Blasi,et al.  DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia , 2010, Proceedings of the National Academy of Sciences.

[29]  Tyrone D. Cannon,et al.  Association of AKT1 with verbal learning, verbal memory, and regional cortical gray matter density in twins , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[30]  Karl J. Friston,et al.  A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.

[31]  Elliot S. Gershon,et al.  Genetic associations with schizophrenia: Meta-analyses of 12 candidate genes , 2008, Schizophrenia Research.

[32]  O. Pietiläinen,et al.  The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland , 2007, Schizophrenia Research.

[33]  P. Gean,et al.  A Role for the PI-3 Kinase Signaling Pathway in Fear Conditioning and Synaptic Plasticity in the Amygdala , 2001, Neuron.

[34]  S. Davis,et al.  Signalling mechanisms mediated by the phosphoinositide 3‐kinase/Akt cascade in synaptic plasticity and memory in the rat , 2006, The European journal of neuroscience.

[35]  Q. Gong,et al.  Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression. , 2011, Schizophrenia bulletin.

[36]  Y. Ahn,et al.  No association between AKT1 polymorphism and schizophrenia: A case–control study in a Korean population and a meta-analysis , 2010, Neuroscience Research.

[37]  Sheng Li,et al.  Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population. , 2007, The Journal of clinical psychiatry.

[38]  D. Shaw,et al.  Genetic association of the AKT1 gene with schizophrenia in a British population , 2010, Psychiatric genetics.

[39]  A. Meyer-Lindenberg,et al.  Intermediate phenotypes and genetic mechanisms of psychiatric disorders , 2006, Nature Reviews Neuroscience.

[40]  J. Lieberman,et al.  AKT1 and Neurocognition in Schizophrenia , 2007, The Australian and New Zealand journal of psychiatry.

[41]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[42]  S. Faraone,et al.  Sustained attention deficits as markers of genetic susceptibility to schizophrenia. , 2000, American journal of medical genetics.

[43]  B. Cornblatt,et al.  Impaired attention, genetics, and the pathophysiology of schizophrenia. , 1994, Schizophrenia bulletin.

[44]  T. Nabeshima,et al.  Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation , 2003, Molecular Psychiatry.

[45]  Barbara A. Cornblatt,et al.  The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients , 1989, Psychiatry Research.

[46]  Michael F. Green,et al.  Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. , 2006, The Journal of clinical psychiatry.

[47]  Vladimir I. Vladimirov,et al.  AKT1 Is Associated with Schizophrenia Across Multiple Symptom Dimensions in the Irish Study of High Density Schizophrenia Families , 2008, Biological Psychiatry.

[48]  A. Green,et al.  Comorbid schizophrenia and substance abuse. , 2006, The Journal of clinical psychiatry.

[49]  Cameron S Carter,et al.  Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. , 2005, Schizophrenia bulletin.

[50]  T. Sotnikova,et al.  Regulation of Akt Signaling by D2 and D3 Dopamine Receptors In Vivo , 2007, The Journal of Neuroscience.

[51]  M. R. Sargolzaee,et al.  Association of AKT1 haplotype with the risk of schizophrenia in Iranian population , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[52]  S. Faraone,et al.  Absence of significant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese population , 2006, Psychiatric genetics.

[53]  Leonardo Fazio,et al.  Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory , 2007, Proceedings of the National Academy of Sciences.

[54]  B. Cornblatt,et al.  The continuous performance test, identical pairs version (CPT-IP) : III: Brain functioning during performance of numbers and shapes subtasks , 1997, Psychiatry Research: Neuroimaging.

[55]  F. McMahon,et al.  Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling , 2011, The Pharmacogenomics Journal.

[56]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[57]  T. Sotnikova,et al.  Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[58]  M. Owen,et al.  Association analysis of AKT1 and schizophrenia in a UK case control sample , 2007, Schizophrenia Research.

[59]  M. Karayiorgou,et al.  Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia , 2004, Nature Genetics.

[60]  J. Javitch,et al.  Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. , 2010, The American journal of psychiatry.

[61]  Norio Ozaki,et al.  Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia. , 2008, Pharmacogenomics.

[62]  T. Sotnikova,et al.  An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior , 2005, Cell.